Connect with us

Hi, what are you looking for?

Alcohol Use Disorder (AUD) Market to Register Incremental Growth During the Forecast Period 2030 | Key Companies – Adial, Opiant, Neurelis, Tonix Pharma, Odyssey Pharma, Alkermes, Bayer, and Others

“Delveinsight Business Research LLP”
DelveInsight’s “Alcohol Use Disorder (AUD) Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Alcohol Use Disorder (AUD) Market Size and Share in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Alcohol Use Disorder (AUD) market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2017 to 2030. It evaluates the current treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Alcohol Use Disorder (AUD) Market

Alcohol Use Disorder (AUD): An Overview

Alcohol use disorder (AUD) is a substance use disorder characterized by excessive, uncontrollable drinking that impacts a person physically, emotionally, and socially. The general population also refers to AUD as alcohol abuse or alcoholism.

Genetic, psychological, social, and environmental factors can impact how drinking alcohol can affect the body and behavior. Theories suggest that drinking has a different and more substantial impact on certain people, leading to AUD. The risk factors include trauma, bariatric surgery, mental health problems, starting drinking at an early age, steady drinking over time, social and cultural factors, and family history of AUD.

Alcohol Use Disorder (AUD) Market Key Facts

  • As per the NHS estimates, “around 9% of men in the UK and 3% of UK women show signs of alcohol dependence”.

  • As per studies by Psychology Today, 29.1% of the US population has experienced an Alcohol Use Disorder of a varying grade at some point in their lifetime. Also, in a 1-year period, approximately 13.9% of the US population experience an AUD.

  • According to the National Survey on Drug Use and Health, in 2018, 5.5% of adults aged 18 years and older had AUD. In adolescents, 12–17 years, 1.6% of people suffered from Alcohol Use Disorder.

Get FREE sample copy at: Alcohol Use Disorder (AUD) Therapeutics Market

Key Benefits of Alcohol Use Disorder (AUD) Market Report

  • The report provides an in-depth analysis of Alcohol Use Disorder (AUD) Market Size and Share till 2030 in the seven major markets.

  • The report will help in developing business strategies by understanding the Alcohol Use Disorder (AUD) Market Trends, key players, and ongoing developments that shape and drive the market growth in the upcoming years.

  • It covers Alcohol Use Disorder (AUD) current treatment practices, emerging drugs, market share of the individual therapies in the 7MM.

  • The report provides a detailed assessment of the Alcohol Use Disorder (AUD) market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors. 

Alcohol Use Disorder (AUD) Market 

Alcohol use disorder (AUD) market size shall grow during the forecast period owing to the launch of upcoming therapies, changing lifestyles, increasing disposable income, and a higher young population.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Alcohol Use Disorder (AUD) market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology. 

The report gives a thorough detail of the Alcohol Use Disorder (AUD) market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Alcohol Use Disorder (AUD) Epidemiology

The epidemiology section covers insights about the historical and current Alcohol Use Disorder (AUD) patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Alcohol Use Disorder (AUD) Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Alcohol Use Disorder (AUD) market or expected to get launched in the market during the study period. The analysis covers Alcohol Use Disorder (AUD) market uptake by drugs; patient uptake by therapies; and sales of each drug. 

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Alcohol Use Disorder (AUD) Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.

The dynamics of the Alcohol Use Disorder (AUD) market are anticipated to change in the coming years owing to the rise in the healthcare spending across the world. 

Alcohol Use Disorder (AUD) Companies:

  • Adial Pharmaceuticals

  • Opiant Pharmaceuticals/ Neurelis

  • Tonix Pharmaceuticals

  • Odyssey Pharmaceutical

  • Alkermes

  • Bayer

And many others.

Alcohol Use Disorder (AUD) Therapies covered in the report include:

  • AD04

  • OPNT002

  • TNX-102 SL

And many others.

Request for Sample @ Alcohol Use Disorder (AUD) Emerging Therapies and Key Companies

Table of Content

1. Key Insights

2. Executive Summary 

3. Alcohol Use Disorder (AUD) Competitive Intelligence Analysis

4. Alcohol Use Disorder (AUD) Market Overview at a Glance

5. Alcohol Use Disorder (AUD) Disease Background and Overview

6. Alcohol Use Disorder (AUD) Patient Journey

7. Alcohol Use Disorder (AUD) Epidemiology and Patient Population

8. Alcohol Use Disorder (AUD) Treatment Algorithm, Current Treatment, and Medical Practices

9. Alcohol Use Disorder (AUD) Unmet Needs

10. Key Endpoints of Alcohol Use Disorder (AUD) Treatment

11. Alcohol Use Disorder (AUD) Marketed Products

12. Alcohol Use Disorder (AUD) Emerging Therapies

13. Alcohol Use Disorder (AUD) Seven Major Market Analysis

14. Attribute Analysis

15. Alcohol Use Disorder (AUD) Market Outlook (7 major markets)

16. Alcohol Use Disorder (AUD) Access and Reimbursement Overview

17. KOL Views on the Alcohol Use Disorder (AUD) Market.

18. Alcohol Use Disorder (AUD) Market Drivers

19. Alcohol Use Disorder (AUD) Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Get FREE sample copy at:

Latest Reports By DelveInsight

Advanced Wound Care (AWC) Market

DelveInsight’s ‘Advanced Wound Care (AWC) Market Insights, Competitive Landscape, and Market Forecast-2026’ report deliver an in-depth understanding of advanced wound care and the historical and forecasted Advanced Wound Care Market Trends in the US, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Nocturnal Enuresis Market

DelveInsight’s “Nocturnal Enuresis Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Nocturnal Enuresis market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States

Written By

You may also like:


There is no stated power in the US Constitution to regulate human reproduction.

Social Media

The United Nations on Thursday launched a campaign against gender-based violence on the internet, complete with the symbol ⓑ.


As the Christmas party season gets underway in Britain, Boris Johnson's government is struggling with mixed messages on Covid-19.


European equities wavered Friday as dealers tracked Omicron news and awaited key US data, while oil prices surged.